Biofrontera
BFRIW
5 hedge funds and large institutions have $11.8K invested in Biofrontera in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
153% more capital invested
Capital invested by funds: $4.67K → $11.8K (+$7.14K)
0.93% less ownership
Funds ownership: 3.91% → 2.98% (-0.93%)
17% less funds holding
Funds holding: 6 → 5 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$258 |
| 2 |
CS
Clear Street
New York
|
-$43 |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$2 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BA
1
Bard Associates
Chicago,
Illinois
| $10.9K | – | – | – |
|
|
CS
2
Clear Street
New York
| $616 | -$43 | -640 | -6% |
|
|
3
UBS Group
Zurich,
Switzerland
| $154 | -$258 | -3,805 | -60% |
|
4
Osaic Holdings
Scottsdale,
Arizona
| $66 | – | – | – |
|
5
US Bancorp
Minneapolis,
Minnesota
| $61 | – | – | – |
|
|
6
Bank of America
Charlotte,
North Carolina
| – | -$2 | -100 | Closed |
|
BFRIW Hedge Fund Activity: Q4 2024 in Review
5 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRIW) for Q4 2024, worth a combined $11.8K — up 153% from $4.67K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BFRIW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.
The largest seller was UBS Group, cutting an estimated $258.
- 5 institutional investors held Biofrontera (BFRIW) as of Q4 2024, down from 6 in Q3 2024.
- Funds reported $11.8K of Biofrontera stock for Q4 2024, up 153% quarter-over-quarter.
- 0 funds opened new Biofrontera positions in Q4 2024 and 1 closed out, a net change of -1 holder.
- The largest Biofrontera seller in Q4 2024 was UBS Group, an estimated $258 sold.
Based on aggregated 13F filings for Q4 2024.